- Home
- KALA vs KUKE Comparison
KALA vs KUKE Comparison
Compare KALA & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- KUKE
- Stock Information
- Founded
- KALA 2009
- KUKE 2002
- Country
- KALA United States
- KUKE China
- Employees
- KALA N/A
- KUKE N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- KUKE Other Consumer Services
- Sector
- KALA Health Care
- KUKE Real Estate
- Exchange
- KALA Nasdaq
- KUKE Nasdaq
- Market Cap
- KALA 26.2M
- KUKE 30.4M
- IPO Year
- KALA 2017
- KUKE 2021
- Fundamental
- Price
- KALA $3.52
- KUKE $3.15
- Analyst Decision
- KALA Strong Buy
- KUKE
- Analyst Count
- KALA 3
- KUKE 0
- Target Price
- KALA $14.00
- KUKE N/A
- AVG Volume (30 Days)
- KALA 55.2K
- KUKE 8.7K
- Earning Date
- KALA 05-14-2025
- KUKE 06-10-2025
- Dividend Yield
- KALA N/A
- KUKE N/A
- EPS Growth
- KALA N/A
- KUKE N/A
- EPS
- KALA N/A
- KUKE N/A
- Revenue
- KALA N/A
- KUKE $9,442,397.00
- Revenue This Year
- KALA N/A
- KUKE N/A
- Revenue Next Year
- KALA N/A
- KUKE N/A
- P/E Ratio
- KALA N/A
- KUKE N/A
- Revenue Growth
- KALA N/A
- KUKE N/A
- 52 Week Low
- KALA $2.92
- KUKE $1.45
- 52 Week High
- KALA $11.20
- KUKE $33.60
- Technical
- Relative Strength Index (RSI)
- KALA 42.83
- KUKE 33.38
- Support Level
- KALA $3.67
- KUKE $3.21
- Resistance Level
- KALA $4.16
- KUKE $3.43
- Average True Range (ATR)
- KALA 0.31
- KUKE 0.22
- MACD
- KALA 0.05
- KUKE -0.14
- Stochastic Oscillator
- KALA 34.20
- KUKE 4.40
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About KUKE Kuke Music Holding Limited
Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.